Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors and Hematologic Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00293345
What this trial is testing

3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06357975
What this trial is testing

Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Genetic Changes (MATCH - Subprotocol C1)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 44
Early research (Phase 1)Study completedNCT02316197
What this trial is testing

Clinical Phase I Study Investigating MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Advanced Solid Tumors or Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Solid TumorsChronic Lymphocytic Leukemia
Merck KGaA, Darmstadt, Germany 31
Early research (Phase 1)Study completedNCT00675350
What this trial is testing

Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors

Who this might be right for
Hematologic Tumors
ChemGenex Pharmaceuticals 12
Early research (Phase 1)Ended earlyNCT00089089
What this trial is testing

Decitabine in Treating Patients With Advanced Refractory Solid Tumors or Lymphomas

Who this might be right for
Hematopoietic/Lymphoid CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439188
What this trial is testing

Testing GSK2636771 as a Potential Targeted Treatment in Cancers With PTEN Loss of Expression (MATCH-Subprotocol P)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT00909207
What this trial is testing

Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing

Who this might be right for
Advanced CancersHematologic DiseasesSolid Tumors
M.D. Anderson Cancer Center 20
Early research (Phase 1)UnknownNCT00003073
What this trial is testing

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsLeukemiaLymphoma+1 more
Pacira Pharmaceuticals, Inc 15
Early research (Phase 1)Ended earlyNCT03690154
What this trial is testing

Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AML

Who this might be right for
Advanced CancerSolid TumorsAcute Myeloid Leukemia Refractory+1 more
Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. 67
Testing effectiveness (Phase 2)Looking for participantsNCT07410676
What this trial is testing

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Who this might be right for
CancerSarcomaLeukaemia+12 more
Essen Biotech 83
Early research (Phase 1)Ended earlyNCT04305249
What this trial is testing

Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorHematological Malignancy
Antengene Therapeutics Limited 36
Early research (Phase 1)Study completedNCT00741234
What this trial is testing

A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

Who this might be right for
Solid TumorsHematologic MalignanciesMyelodysplastic Syndrome
S*BIO 85
Early research (Phase 1)Study completedNCT00008125
What this trial is testing

Combination Chemotherapy With or Without Filgrastim in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
University of Pittsburgh 25
Not applicableLooking for participantsNCT02534649
What this trial is testing

Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials

Who this might be right for
Solid TumorHematological Malignancy
Institut Bergonié 10,000
Testing effectiveness (Phase 2)Study completedNCT04439240
What this trial is testing

Testing AZD4547 as a Potential Targeted Treatment in Cancers With FGFR Genetic Changes (MATCH-Subprotocol W)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 52
Testing effectiveness (Phase 2)Active Not RecruitingNCT06400225
What this trial is testing

Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 35
Not applicableStudy completedNCT01869218
What this trial is testing

Feasibility Study of Genomic Sequencing to Find Potential Targets for Personalized Therapy

Who this might be right for
Hematologic Neoplasms
University of Colorado, Denver 40
Testing effectiveness (Phase 2)Study completedNCT02561455
What this trial is testing

Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial

Who this might be right for
Advanced Solid TumorsAcute Myeloid Leukemia
Astellas Pharma Global Development, Inc. 9
Not applicableStudy completedNCT03222258
What this trial is testing

Prospective Cohort Study Depending on the Use of Palliative Care for Advanced Stage of Cancer Patients

Who this might be right for
Stage IV Breast CancerStage IV Pancreatic CancerStage IV Colon Cancer+9 more
Seoul National University Hospital 444
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Next Page